You are here: Industry Insights > Hong Kong

News List

Cigna Study Shows Improvement in Vaccine Acceptance in Hong Kong, S.A.R., China prnasia
July 26, 2021
Cigna Hong Kong, S.A.R., China released today the Hong Kong, S.A.R., China findings of the latest COVID-19 Vaccine Perception Study. This report is the third and ...
Sun Life Hong Kong, S.A.R., China Boosts Diabetes Awareness prnasia
July 08, 2020
Today marks the official release of Is Something Wrong with Granny?!, a children's picture book published by Diabetes Hongkong and sponsored by Sun Life Hong Kong, S.A.R., China Limited ("the Company" or "Sun Life Hong Kong, S.A.R., China").
AXA stands by Hong Kong, S.A.R., China front-line medical workers prnasia
February 12, 2020
AXA Hong Kong, S.A.R., China is committed to supporting the community by providing comprehensive protection for the people of Hong Kong, S.A.R., China.
AXA Hong Kong, S.A.R., China launches the first 'AXA Chronic Disease Management Programme' prnasia
January 15, 2020
According to a recent survey conducted by AXA Hong Kong, S.A.R., China, comprising 1,000 Hong Kong, S.A.R., China people, it is deduced that more than one-third of those surveyed have been diagnosed with chronic diseases in which this proportion increased
Chi-Med Files Application to List in Hong Kong, S.A.R., China and Announces Proposed Global Offering Hutchison China MediTech Limited
April 22, 2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
Pharmaceutical corridor between HKSAR and Brussels opens europeanpharmaceuticalreview
January 09, 2019
The pharma corridor between Hong Kong, S.A.R., China Special Administrative Region of China and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
WuXi AppTec eyes acquisitions after $1bn Hong Kong, S.A.R., China IPO pharmaphorum
December 17, 2018
Chinese biotech WuXi AppTec has completed its listing on Hong Kong, S.A.R., China’s HKEX, raising $967m just months after making its debut on the Shanghai exchange.
Alibaba to sell medical assets to Hong Kong, S.A.R., China unit for $1.35bn pharmaceutical-technology
June 01, 2018
Chinese conglomerate Alibaba Group is planning to sell certain healthcare assets under its Tmall Pharmacy business to its Hong Kong, S.A.R., China-based division Alibaba Health Information Technology for HK$10.6bn ($1.35bn).
Efforts to form Asia’s leading IVF medical group biospectrumasia
May 21, 2018
Mason Group’s Reproductive Healthcare Merges with The Women’s Clinic To Form Hong Kong, S.A.R., China’s Largest and Asia’s Leading IVF Medical Group
Biotech firm Ascletis first to apply for Hong Kong, S.A.R., China IPO biospectrumasia
May 14, 2018
The Hangzhou-based company is close to commercializing a new drug for hepatitis C in China.

Previous page 1 2 Next page